Ajanta Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,421.64 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.40 per cent from ₹1,374.84 crore. This corresponds to a year-on-year *(YoY) growth of 21.47 per cent.
Operating Profit
Operating Profit stands at ₹333.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.77 per cent from ₹382.24 crore. This corresponds to a year-on-year *(YoY) growth of 12.20 per cent.
PBDT
PBDT stands at ₹392.48 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.39 per cent from ₹402.11 crore. This corresponds to a year-on-year *(YoY) growth of 26.94 per cent.
Profit Before Tax
Profit Before Tax stands at ₹347.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.20 per cent from ₹358.60 crore. This corresponds to a year-on-year *(YoY) growth of 28.84 per cent.
Net Profit
Net Profit stands at ₹266.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.58 per cent from ₹273.77 crore. This represents a 18.40 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Ajanta Pharma Ltd News
Ajanta Pharma Ltd Earnings
- YOY
- QOQ
Ajanta Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Ajanta Pharma Ltd Research Reports
Ajanta Pharma Ltd Financial Reports
Ajanta Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -3.71% | -2.88% | -0.26% | 20.07% | 24.95% | 21.57% |
| Ipca Labs. | -0.74% | -3.66% | 7.03% | 14.75% | 21.36% | 18.93% |
| Anthem Bioscienc | -1.29% | -2.74% | -0.66% | -0.03% | 30.04% | 1.91% |
| Glaxosmi. Pharma | 0.81% | 1.22% | 6.85% | 2.90% | 7.56% | -18.54% |
| Gland Pharma | 0.03% | -2.94% | 0.64% | 34.61% | 42.48% | 16.36% |
| Emcure Pharma | 0.60% | 1.14% | 1.83% | 15.02% | 26.77% | 34.22% |
| Wockhardt | -0.22% | -4.19% | -5.49% | 27.84% | 36.63% | 9.31% |
Company Info
Company Information
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah